Status:
ENROLLING_BY_INVITATION
Treatment of Residual Refraction Errors 6 Months After Trifocal IOL Implantation With Relex-Smile
Lead Sponsor:
Eye Hospital Pristina Kosovo
Conditions:
Pseudophakia
Myopia
Eligibility:
All Genders
20-45 years
Phase:
NA
Brief Summary
Successful treatment of residual refraction 6 months after IOL Implantation with Relex-Smile.
Detailed Description
Residual refractive errors(myopia 50% and hyperopia 30%) are the main problems at patients after IOL Implantation. The residual refraction (myopic and hyperopic) after IOL Implantation is difficult t...
Eligibility Criteria
Inclusion
- residual hypermetropic, myopic refraction on pseudophakic patients
- low visual acuity
Exclusion
- active anterior segment pathologic features,
- previous corneal or anterior segment surgery,
- glaucoma,
- retinal detachment
Key Trial Info
Start Date :
June 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04712318
Start Date
June 1 2016
End Date
June 1 2026
Last Update
August 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eye Hospital Pristina
Pristina, Kosovo, 10000